Antiviral drugs for seasonal influenza 2014-2015

Medical Letter on Drugs and Therapeutics

Volumn 56, Issue 1457, 2014, Pages 121-123

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; OSELTAMIVIR; PERAMIVIR; RIMANTADINE; ZANAMIVIR; ENZYME INHIBITOR; SIALIDASE;

ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; AUTOMUTILATION; BRONCHOSPASM; CHEMOPROPHYLAXIS; DELIRIUM; FEVER; HEADACHE; INFLUENZA VIRUS A; INFLUENZA VIRUS B; NAUSEA AND VOMITING; NOTE; PREGNANCY; SEASONAL INFLUENZA; VIRUS REPLICATION; ANTAGONISTS AND INHIBITORS; ENZYMOLOGY; HUMAN; IMMUNOLOGY; INFLUENZA, HUMAN; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; ORAL DRUG ADMINISTRATION; SEASON;

ADMINISTRATION, INHALATION; ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; ENZYME INHIBITORS; HUMANS; INFLUENZA, HUMAN; NEURAMINIDASE; OSELTAMIVIR; SEASONS; ZANAMIVIR;

EID: 84915803921     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (13)

1. Influenza vaccine for 2014-2015. Med Lett Drugs Ther 2014; 56: 97.
2. AE Fiore et al. Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011; 60: 1.
3. SA Harper et al. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 1003.
4. JK Louie et al. Neuraminidase inhibitors for critically ill children with influenza. Pediatrics 2013; 132: e1539.
5. SG Muthuri et al. Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. Lancet Respir Med 2014; 2: 395.
6. JK Louie et al. Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09. Clin Infect Dis 2012; 55: 1198.
7. RE Ariano et al. Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. CMAJ 2010; 182: 357.
8. QM Le et al. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N Engl J Med 2010; 362: 86.
9. AH Gaur et al. Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza. N Engl J Med 2010; 362: 88.
10. S Toovey et al. Post-marketing assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: an updated review. Adv Ther 2012; 29: 826.
11. CDC. Influenza antiviral medications: summary for clinicians. Available at www. cdc. gov/flu/professionals/antivirals/summary-clinicians. htm. Accessed November 21, 2014.
12. MH Yudin. Risk management of seasonal influenza during pregnancy: current perspectives. Int J Womens Health 2014; 6: 681.
13. M Wollenhaupt et al. The safety of oseltamivir in pregnancy: an updated review of post-marketing data. Pharmacoepidemiol Drug Saf 2014; 23: 1035.